Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 5, 2022
Lower Limbs are the Most Difficult-to-Treat Body Region of Patients with Psoriasis: Pooled Analysis of CLEAR and CLARITY Studies of Secukinumab Versus Ustekinumab by Body Region
Miguel Alpalhão, Joana Duarte, Rita Diogo, et al.
RMD Open
|
June 15, 2023
Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis
Mathias Cardner, Danny Tuckwell, Anna Kostikova, et al.
Biometrical Journal. Biometrische Zeitschrift
|
November 27, 2022
Comparing algorithms for characterizing treatment effect heterogeneity in randomized trials
Sophie Sun, Konstantinos Sechidis, Yao Chen, et al.
Toxicologic Pathology
|
February 24, 2021
Biomarker-Based Classification and Localization of Renal Lesions Using Learned Representations of Histology-A Machine Learning Approach to Histopathology
Christophe A C Freyre, Stephan Spiegel, Caroline Gubser Keller, et al.
Pharmaceutical Statistics
|
December 27, 2024
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
Konstantinos Sechidis, Sophie Sun, Yao Chen, et al.
Journal of the American Academy of Dermatology
|
August 14, 2023
Assessing the validity and clinical meaningfulness of skin pain response (NRS30) assessed using numerical rating scale in hidradenitis suppurativa: Results from the SUNSHINE and SUNRISE trials
Xiaoling Wei, Anna Passera, Elisa Muscianisi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 5, 2024
New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials
Anna Passera, Elisa Muscianisi, David Demanse, et al.
Therapeutic Innovation & Regulatory Science
|
November 24, 2025
In Silico Clinical Trials in Drug Development: A Systematic Review
Bohua Chen, Lucia Chantal Schneider, Christian Röver, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 13, 2011
AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials
Daniela Berg, Jana Godau, Claudia Trenkwalder, et al.
American Journal of Human Genetics
|
September 2, 2023
Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background
Cong Zhang, Konstantin Shestopaloff, Benjamin Hollis, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 5, 2022
Lower Limbs are the Most Difficult-to-Treat Body Region of Patients with Psoriasis: Pooled Analysis of CLEAR and CLARITY Studies of Secukinumab Versus Ustekinumab by Body Region
Miguel Alpalhão, Joana Duarte, Rita Diogo, et al.
RMD Open
|
June 15, 2023
Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis
Mathias Cardner, Danny Tuckwell, Anna Kostikova, et al.
Biometrical Journal. Biometrische Zeitschrift
|
November 27, 2022
Comparing algorithms for characterizing treatment effect heterogeneity in randomized trials
Sophie Sun, Konstantinos Sechidis, Yao Chen, et al.
Toxicologic Pathology
|
February 24, 2021
Biomarker-Based Classification and Localization of Renal Lesions Using Learned Representations of Histology-A Machine Learning Approach to Histopathology
Christophe A C Freyre, Stephan Spiegel, Caroline Gubser Keller, et al.
Pharmaceutical Statistics
|
December 27, 2024
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
Konstantinos Sechidis, Sophie Sun, Yao Chen, et al.
Journal of the American Academy of Dermatology
|
August 14, 2023
Assessing the validity and clinical meaningfulness of skin pain response (NRS30) assessed using numerical rating scale in hidradenitis suppurativa: Results from the SUNSHINE and SUNRISE trials
Xiaoling Wei, Anna Passera, Elisa Muscianisi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 5, 2024
New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials
Anna Passera, Elisa Muscianisi, David Demanse, et al.
Therapeutic Innovation & Regulatory Science
|
November 24, 2025
In Silico Clinical Trials in Drug Development: A Systematic Review
Bohua Chen, Lucia Chantal Schneider, Christian Röver, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 13, 2011
AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials
Daniela Berg, Jana Godau, Claudia Trenkwalder, et al.
American Journal of Human Genetics
|
September 2, 2023
Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background
Cong Zhang, Konstantin Shestopaloff, Benjamin Hollis, et al.
Page
of 4